Autres langues Beacon Pharmaceuticals PLC

Actions

BEACONPHAR

BD0482BECON5

Produits pharmaceutiques

Cours en clôture Dhaka S.E. 17/08/2026			Varia. 5j.	Varia. 1 janv.
105,90 ^BDT	-1,12%		-1,12%	+1,24%

02/07	Beacon Pharmaceuticals Limited annonce la nomination de Md. Emroj Hossain au poste de secretaire general, a compter du 1er juillet 2026	CI
01/06	Beacon Pharmaceuticals PLC publie ses résultats pour le troisième trimestre et les neuf mois clos le 31 mars 2026	CI

Autres langues

02/07	Beacon Pharmaceuticals Limited Announces Appointment of Md. Emroj Hossain as Company Secretary, Effective July 1, 2026
01/06	Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026
03/04	Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025
17/12	Beacon Pharmaceuticals Announces Appointment of Mr. Ulfat Karim as Managing Director, Effective December 14, 2025
23/10/25	Beacon Pharmaceuticals PLC Recommends Cash Dividend for the Year Ended June 30, 2025
23/10/25	Beacon Pharmaceuticals PLC announces Annual dividend, payable on January 22, 2026
03/02/25	Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024
13/11/24	Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2024
30/09/24	Beacon Pharmaceuticals plc Recommends Dividend for the Year Ended June 30, 2024
16/05/24	Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
13/02/24	Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
30/01/24	Beacon Pharmaceuticals plc Announces Appointment of Md. Sahabuddin FCS as Company Secretary
24/01/24	Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023
05/12/23	Beacon Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended June 30, 2023
23/10/23	Beacon Pharmaceuticals plc Recommends Cash Dividend for the Year Ended June 30, 2023
13/08/23	Beacon Pharmaceuticals plc Appoints Mr. Ulfat Karim as the Director and Chief Operating Officer
19/06/23	Beacon Pharmaceuticals PLC Announces Appointment of Jalal Uddin as Chief Financial Officer
11/05/23	Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as CFO
11/05/23	Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as Director (Finance & Accounts)
04/05/23	Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
16/04/23	Beacon Pharmaceuticals Limited will Change its Name to Beacon Pharmaceuticals PLC
14/02/23	Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
22/11/22	Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022
22/11/22	Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022
26/10/22	Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022